Annual EBITDA
-$1.28 M
NaN%
December 31, 2022
Summary
- As of February 10, 2025, IQMD annual EBITDA is -$1.28 million
Performance
IQMD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$314.90 K
-$46.30 K-17.24%
December 31, 2022
Summary
- As of February 10, 2025, IQMD quarterly EBITDA is -$314.90 thousand, with the most recent change of -$46.30 thousand (-17.24%) on December 31, 2022.
- Over the past year, IQMD quarterly EBITDA has dropped by -$19.10 thousand (-6.46%).
Performance
IQMD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$1.28 M
-$314.90 K-32.49%
December 31, 2022
Summary
- As of February 10, 2025, IQMD TTM EBITDA is -$1.28 million, with the most recent change of -$314.90 thousand (-32.49%) on December 31, 2022.
- Over the past year, IQMD TTM EBITDA has dropped by -$967.30 thousand (-305.43%).
Performance
IQMD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IQMD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -6.5% | -305.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IQMD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | >+9999.0% | +28.5% | +6043.5% | at low |
| 5 y | 5-year | at high | at low | >+9999.0% | +28.5% | +6073.1% | at low |
| alltime | all time | at high | at low | >+9999.0% | +28.5% | +6073.1% | at low |
Intelligent Medicine Acquisition EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$1.28 M | -$314.90 K(+17.2%) | -$1.28 M(+32.5%) |
| Sep 2022 | - | -$268.60 K(-33.6%) | -$969.10 K(+38.3%) |
| Jun 2022 | - | -$404.70 K(+36.8%) | -$700.60 K(+121.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$295.80 K(>+9900.0%) | -$316.70 K(+1415.3%) |
| Sep 2021 | - | -$100.00(-99.5%) | -$20.90 K(+0.5%) |
| Jun 2021 | - | -$20.80 K | -$20.80 K |
FAQ
- What is Intelligent Medicine Acquisition annual EBITDA?
- What is the all time high annual EBITDA for Intelligent Medicine Acquisition?
- What is Intelligent Medicine Acquisition quarterly EBITDA?
- What is the all time high quarterly EBITDA for Intelligent Medicine Acquisition?
- What is Intelligent Medicine Acquisition quarterly EBITDA year-on-year change?
- What is Intelligent Medicine Acquisition TTM EBITDA?
- What is the all time high TTM EBITDA for Intelligent Medicine Acquisition?
- What is Intelligent Medicine Acquisition TTM EBITDA year-on-year change?
What is Intelligent Medicine Acquisition annual EBITDA?
The current annual EBITDA of IQMD is -$1.28 M
What is the all time high annual EBITDA for Intelligent Medicine Acquisition?
Intelligent Medicine Acquisition all-time high annual EBITDA is -$1.28 M
What is Intelligent Medicine Acquisition quarterly EBITDA?
The current quarterly EBITDA of IQMD is -$314.90 K
What is the all time high quarterly EBITDA for Intelligent Medicine Acquisition?
Intelligent Medicine Acquisition all-time high quarterly EBITDA is -$100.00
What is Intelligent Medicine Acquisition quarterly EBITDA year-on-year change?
Over the past year, IQMD quarterly EBITDA has changed by -$19.10 K (-6.46%)
What is Intelligent Medicine Acquisition TTM EBITDA?
The current TTM EBITDA of IQMD is -$1.28 M
What is the all time high TTM EBITDA for Intelligent Medicine Acquisition?
Intelligent Medicine Acquisition all-time high TTM EBITDA is -$20.80 K
What is Intelligent Medicine Acquisition TTM EBITDA year-on-year change?
Over the past year, IQMD TTM EBITDA has changed by -$967.30 K (-305.43%)